databases > DOI:10.25504/FAIRsharing.m3jtpg

ready ChEMBL

Recommended
General Information
ChEMBL is an open large-scale bioactivity database containing information largely manually extracted from the medicinal chemistry literature. Information regarding the compounds tested (including their structures), the biological or physicochemical assays performed on these and the targets of these assays are recorded in a structured form, allowing users to address a broad range of drug discovery questions.


In the following recommendations:




How to cite this record FAIRsharing.org: ChEMBL; ChEMBL; DOI: https://doi.org/10.25504/FAIRsharing.m3jtpg; Last edited: Jan. 17, 2019, 11:39 a.m.; Last accessed: Mar 26 2019 1:57 p.m.


This record is maintained by agaulton  ORCID

Record updated: Jan. 17, 2019, 11:39 a.m. by The FAIRsharing Team.

Show edit history



Support

General

Additional Information

TeSS training resources 

Chembl quick tour

Chembl walkthrough webinar

Chembl exploring bioactive drug like molecules




Access / Retrieve Data


Publications

ChEMBL: a large-scale bioactivity database for drug discovery.

Gaulton A., Bellis LJ., Bento AP., Chambers J., Davies M., Hersey A., Light Y., McGlinchey S., Michalovich D., Al-Lazikani B., Overington JP.,
Nucleic Acids Res. 2012

View Paper (PubMed)

The ChEMBL bioactivity database: an update

Bento AP, Gaulton A, Hersey A, Bellis LJ, Chambers J, Davies M, Krüger FA, Light Y, Mak L, McGlinchey S, Nowotka M, Papadatos G, Santos R, Overington JP.
Nucleic Acids Res. 2013

View Paper (PubMed)

Related Standards

Reporting Guidelines

No guidelines defined

Models and Formats

No syntax standards defined

Identifier Schemas

No identifier schema standards defined

Metrics

No metrics standards defined




Credit

Record Maintainer

Funds

Maintains

Grant Number(s)

  • 115002 (Innovative Medicines Initiative (IMI), Brussles, Belgium)

  • 602156 (European Commission under FP7 Grant Agreement)

  • 654248 (The CORBEL Project)

  • 681002 (EU-ToxRisk)

  • CTTV008 (Centre for Therapeutic Target Validation, Cambridge, UK)

  • U54CA189205 (NIH Common Fund, USA)

  • WT086151/Z/08/Z (Wellcome Trust, UK)